Published: 19th January 2023
Examples of projects that have already been awarded funding include the application of artificial intelligence to aid histopathological lymph node assessment in breast cancer patients and the development of digital droplet PCR assays to monitor chimeric antigen receptor T cell (CAR-T) levels in patients with haematological malignancies following CAR-T therapy.